The covered call is one of the most popular income strategies in options trading. The problem is the entry cost. On a $150 stock, owning 100 shares means $15,000 in capital tied up in a single position before you've sold a single call. For most retail traders, that's a significant chunk of their account doing one job.
The synthetic covered call solves that problem. Same income profile, fraction of the capital. Here's exactly how it works — and when it's actually better than holding the real shares.
The Problem With Regular Covered Calls
A traditional covered call requires you to own 100 shares of stock. That's the "cover" — if your short call gets exercised, you have shares to deliver. The income strategy works because you collect premium every 30 to 45 days while holding the position.
The capital requirement is the friction point. $15,000 in a $150 stock means you need a meaningful account just to run one covered call position. Run three positions and you've committed $45,000. For traders trying to diversify their premium income across multiple names without overconcentrating, the share requirement creates a real constraint.
There's also opportunity cost. $15,000 sitting in 100 shares of one stock isn't available for anything else. If a better setup appears somewhere else, you either pass on it or liquidate shares you might not want to sell.
What a Synthetic Covered Call Actually Is
A synthetic covered call replaces the 100 shares with a deep in-the-money long call option — typically a LEAPS with 12 to 24 months to expiration and a delta of 0.80 or higher. That long call behaves similarly to owning 100 shares because its high delta means it moves nearly dollar-for-dollar with the stock.
Against that long LEAPS call, you sell a short-dated call above the current stock price — exactly like a traditional covered call. The short call collects premium every month. The long LEAPS provides cover if the short call gets exercised.
The structure is also called a Poor Man's Covered Call (PMCC) or a diagonal spread. The names vary but the mechanics are identical — long deep ITM call, short OTM call, same income profile as a traditional covered call at significantly lower capital cost.
The Math That Actually Matters
Let's put real numbers on this so the capital efficiency argument is concrete.
Traditional covered call setup:
Stock price: $150. You buy 100 shares. Capital required: $15,000. You sell the $160 strike call expiring in 35 days for $2.80. Premium collected: $280. Monthly yield on capital: 1.87%.
Synthetic covered call setup:
Same stock at $150. Instead of buying shares, you buy the $120 strike LEAPS call expiring in 18 months. Delta: 0.87. Cost: $3,400. Capital required: $3,400. You sell the same $160 strike call expiring in 35 days for $2.80. Premium collected: $280. Monthly yield on capital: 8.2%.
Same $280 in premium. Same upside cap at $160. But you deployed $3,400 instead of $15,000. The annualized yield on capital deployed is more than four times higher in the synthetic structure.
The freed capital — $11,600 — is now available for other positions, cash, or different strategies. That's the capital efficiency argument in numbers. It's not theoretical. It's straightforward math on the same trade.
When This Setup Makes Sense
High-priced stocks. The synthetic structure is most compelling on expensive stocks where 100 shares would represent an uncomfortable concentration of capital. NVDA at $174 means $17,400 per covered call position. A LEAPS-based synthetic might cost $3,500 to $5,000 — same income potential, 70-80% less capital at risk.
Capital-efficient accounts. If you're running a smaller account and want to run covered calls across multiple names without tying up all your capital in shares, synthetic positions let you diversify your premium income. Three synthetic positions might require the same capital as one traditional covered call position on an expensive stock.
When you want directional exposure without full capital commitment. A LEAPS call gives you upside participation in a stock you're long-term bullish on, while the short calls you sell against it reduce your net cost basis over time. You're expressing a bullish view without locking up full share capital. If the stock runs significantly, you profit on the long LEAPS. If it grinds sideways, you collect premium.
IRA and restricted accounts. Depending on your broker and account type, selling cash secured puts may be restricted. A LEAPS-based synthetic covered call is structured as a spread — two options, no naked short positions — which is often permissible in accounts where other strategies are restricted. Check with your broker for your specific account's options approval level.
When It Doesn't Make Sense
Dividend capture. When you own shares, you receive dividends. When you own a LEAPS call, you don't. On dividend-paying stocks with meaningful yields, the synthetic structure gives up real income that the traditional covered call captures. If dividend income is part of your return calculation, factor it in before switching to a synthetic.
Low IV environments. The synthetic structure works because you collect premium on short calls every month. In a low-IV environment — VIX at 13, stock IV rank at 15 — the premium on the short call is thin. Meanwhile, you're carrying a LEAPS position that has its own time decay working against you. In low-IV environments, the math of the synthetic can deteriorate faster than a traditional covered call because you're losing on both ends — thin premium coming in, theta decay going out.
When you want simplicity. A synthetic covered call has two legs to manage instead of one. The LEAPS needs to be monitored for time decay, early assignment risk, and eventual roll decisions. If you want a straightforward income trade without the added complexity, owning shares and selling calls is the cleaner structure.
The One Thing People Get Wrong
The most common mistake with synthetic covered calls is treating the LEAPS as if it's free.
It isn't. Your long LEAPS call loses time value every day — more slowly than a short-dated option because of its long expiration, but the decay is real and it compounds over 18 months. The premium you collect from monthly short calls needs to more than offset that decay over time, or the structure is quietly losing ground even when your short calls are expiring worthless.
Track your net cost basis on the LEAPS — what you paid minus all the premium you've collected against it. That number tells you whether the structure is working. If your net cost basis is declining every month, the synthetic is performing as intended. If it's flat or rising because the short call premium isn't keeping up with LEAPS decay, something needs to change — either the ticker, the IV environment, or the structure itself.
How to Find Candidates Worth Trading
Before you build a synthetic covered call position, two things need to be true about the ticker you're considering.
First, IV rank needs to be elevated — ideally above 40. If the short call premium is thin because IV is depressed, the monthly income won't offset your LEAPS decay and the math won't work. You need to be selling the short call when options are expensive relative to the stock's own history.
Second, the historical probability of the short strike expiring worthless needs to support the trade. You're not just looking for high premium — you're looking for high probability of keeping that premium. A short call with 65% historical probability of expiring worthless is a very different trade than one at 82%, even if the dollar premium looks similar.
I run this check in StrikeScan before I touch anything — scan for tickers with elevated IV rank, pull the short call's historical and Monte Carlo probability, and see if the math holds up before committing to the LEAPS purchase. It saves me from building a two-leg position on a stock where the premium isn't actually there to support the structure. Free while it's in beta at StrikeScan.com.
The Bottom Line
The synthetic covered call strategy gives you the same income profile as a traditional covered call at a fraction of the capital cost. It makes the most sense on expensive stocks, smaller accounts running multiple positions, and situations where you want directional exposure without full capital commitment.
The tradeoffs are real — no dividends, LEAPS theta working against you, added complexity of managing two legs. But for traders who understand those tradeoffs and account for them, the capital efficiency of the synthetic structure is a genuine advantage that compounds meaningfully over time.
The key is running it on the right stocks in the right IV environment, tracking your net cost basis honestly, and not treating the LEAPS as if it came for free.
Disclosure: I am the founder of StrikeScan, the platform referenced in this article. This is not financial advice.